Study Stopped
No Funding was acquired.
Ocular Hypertension And Yoga Study
OHAYS
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The investigators aim to pilot test the efficacy of a yoga intervention designed specifically for individuals with ocular hypertension. The investigators would like to find out if a combination of breathing, postures and meditation may help to reduce intraocular pressure in the short term after each yoga session, and also long-term across an 8-week program. Subjects will participate in the yoga intervention sessions led by Dr. Pamela Jeter once a week at the investigators center, and will be asked to practice at home at least twice a week using a audio CD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2011
CompletedFirst Posted
Study publicly available on registry
October 5, 2011
CompletedStudy Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 26, 2014
May 1, 2014
6 months
September 20, 2011
May 23, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Intraocular Pressure (IOP)
Baseline IOP measures will be obtained at two visits prior to the intervention. At each weekly visit, we will obtain two series of IOP measures about one hour apart, similar to the sequence that will be used during the weekly yoga intervention, to estimate trends over an 8-week intervention period. Post-intervention IOP will be measured at a single session one week after the yoga intervention has ended, and at a follow-up visit one month after the yoga intervention. Subjects will be masked to the IOP results until they have completed the study.
Change in IOP from mean baseline at 8-weeks (end of yoga intervention period)
Secondary Outcomes (12)
Body Mass Index (BMI) (i.e. weight and height)
Week 0 and week 8
Blood pressure
once a week for a total period of 11 weeks; then one additional measure 1 month later
Respiratory Rate (RR)
Week 0 and Week 8
Pittsburgh Sleep Quality Index (PSQI)
Week 0 and Week 8
Perceived Stress Scale (PSS)
Week 0 and Week 8
- +7 more secondary outcomes
Study Arms (1)
Yoga
EXPERIMENTALYoga group
Interventions
Three yoga classes per week for 8 weeks.
Eligibility Criteria
You may qualify if:
- Age 18+
- Diagnosis of ocular hypertension not requiring treatment of IOP
- IOP in at least one eye ≥ 21 mm Hg
- Normal Humphrey 24-2 or 30-2 visual fields for both eyes as determined by the patient's glaucoma specialist
- Best-corrected visual acuity better than 20/40 in both eyes
- Being healthy to the extent that participation in yoga therapy would not exacerbate any existing disease conditions;
- Participants do not engage in athletic activity on a regular basis (i.e. are sedentary)
- Able and willing to participate on a weekly basis for the 11-week intervention;
- Informed consent
You may not qualify if:
- VISUAL HISTORY
- Any visual field loss in either eye consistently detected with Humphrey Visual Field 30-2 or 24-2
- Inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (cognitive impairment)
- Previous intraocular surgery, except for uncomplicated extracapsular cataract extraction with posterior chamber-intraocular lens implant and no escape of vitreous to the anterior chamber, strabismus, cosmetic eyelid surgery, and radial keratotomy
- Secondary causes of elevated IOP, including ocular and systemic corticosteroid use
- Angle closure glaucoma or anatomically narrow angles-75% of the circumference of the angle must be grade 2 or more by Shaffer criteria
- Pigmentary glaucoma
- Congenital glaucoma
- Other diseases that cause visual field loss or optic disc abnormalities
- Difference in cup-disc ratios (horizontal by contour) between the two eyes of \>0.2
- Background diabetic retinopathy, defined as at least 1 microaneurysm seen on ophthalmoscopy with dilated pupil, or any retinal hemorrhage
- SPECIFIC SYSTEMIC DISEASES/CONDITIONS
- Abdominal Aneurism
- Cancer, metastatic
- Fibromyalgia, severe
- +35 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lions Vision and Research Rehabilitation
Baltimore, Maryland, 21205, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ava Bittner, OD, PhD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Research Fellow
Study Record Dates
First Submitted
September 20, 2011
First Posted
October 5, 2011
Study Start
June 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
May 26, 2014
Record last verified: 2014-05